Literature DB >> 15667538

First description of somatic mosaicism in MYH9 disorders.

Shinji Kunishima1, Tadashi Matsushita, Takao Yoshihara, Yoko Nakase, Kentaro Yokoi, Motohiro Hamaguchi, Hidehiko Saito.   

Abstract

MYH9 disorders are characterized by giant platelets, thrombocytopenia, and Dohle body-like cytoplasmic granulocyte inclusion bodies that result from mutations in MYH9, which encodes non-muscle myosin heavy chain-A (NMMHCA). These disorders are known to be transmitted in an autosomal dominant manner, although about 20% of cases are considered to be sporadic. We report here the first case of a MYH9 disorder because of somatic mosaicism. The patient was the father of a male with typical May-Hegglin anomaly. The father had normal platelet counts, however, both normal-sized and giant platelets were observed on his peripheral blood smears. In addition, 14% of neutrophils contained inclusion bodies and the rest showed a normal morphology. Quantitative fluorescent polymerase chain reaction analysis showed that only 6% of DNA from peripheral blood leucocytes harboured the mutation. The mosaicism was demonstrated at a similar rate in different tissues, buccal mucosa cells and hair bulb cells, implying that the mutation had occurred before gastrulation. Mosaicism might account for some de novo mutations in MYH9 disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15667538     DOI: 10.1111/j.1365-2141.2004.05323.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  A Trp33Arg mutation at exon 1 of the MYH9 gene in a Korean patient with May-Hegglin anomaly.

Authors:  Moon Ju Jang; Hyun-Jeong Park; So Young Chong; Ji Young Huh; In-Ho Kim; Ja-Hyun Jang; Hee-Jin Kim; Doyeun Oh
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

Review 2.  MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.

Authors:  Alessandro Pecci; Xuefei Ma; Anna Savoia; Robert S Adelstein
Journal:  Gene       Date:  2018-04-19       Impact factor: 3.688

3.  Renal manifestations of patients with MYH9-related disorders.

Authors:  Kyoung Hee Han; HyunKyung Lee; Hee Gyung Kang; Kyung Chul Moon; Joo Hoon Lee; Young Seo Park; Il Soo Ha; Hyo Seop Ahn; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-01-06       Impact factor: 3.714

4.  Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants.

Authors:  Loredana Bury; Karyn Megy; Jonathan C Stephens; Luigi Grassi; Daniel Greene; Nick Gleadall; Karina Althaus; David Allsup; Tadbir K Bariana; Mariana Bonduel; Nora V Butta; Peter Collins; Nicola Curry; Sri V V Deevi; Kate Downes; Daniel Duarte; Kim Elliott; Emanuela Falcinelli; Bruce Furie; David Keeling; Michele P Lambert; Rachel Linger; Sarah Mangles; Rutendo Mapeta; Carolyn M Millar; Christopher Penkett; David J Perry; Kathleen E Stirrups; Ernest Turro; Sarah K Westbury; John Wu; Nihr BioResource; Keith Gomez; Kathleen Freson; Willem H Ouwehand; Paolo Gresele; Ilenia Simeoni
Journal:  Hum Mutat       Date:  2019-10-15       Impact factor: 4.878

5.  Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders.

Authors:  Béatrice Saposnik; Sylvie Binard; Odile Fenneteau; Alan Nurden; Paquita Nurden; Marie-Françoise Hurtaud-Roux; Nicole Schlegel
Journal:  Mol Genet Genomic Med       Date:  2014-02-07       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.